About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Oncology
›
Top Articles
Oncology
Oncology
3.6
(top 4%)
Impact Factor
3.9
(top 4%)
extended IF
106
(top 3%)
H-Index
1.8K
authors
5.4K
papers
107.8K
citations
6.5K
citing journals
47.3K
citing authors
Most Cited Articles of Oncology
Title
Year
Citations
VEGF as a key mediator of angiogenesis in cancer
2005
1K
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer
2007
567
Neoplastic characteristics of the DNA found in the plasma of cancer patients
1989
510
VEGF as a therapeutic target in cancer
2005
450
Biology of HER2 and its importance in breast cancer
2001
442
Results of a nationwide study on the three-field lymph node dissection of esophageal cancer
1991
435
Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group
2000
403
Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus
2001
369
Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions
1997
333
EGFR signaling and drug discovery
2009
324
The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer
2007
324
Antitumor activity of beta-carotene, canthaxanthin and phytoene
1982
304
The role of the IGF system in cancer: from basic to clinical studies and clinical applications
2002
272
Adherence to endocrine therapy for breast cancer
2006
256
Decreased expression of microRNA-143 and -145 in human gastric cancers
2009
244
Global Epidemiology of Head and Neck Cancers: A Continuing Challenge
2016
239
Managing patients treated with bevacizumab combination therapy
2005
232
A review and update on cholangiocarcinoma
2004
215
Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer
2010
201
The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy
2000
198
Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future
2002
186
Gender disparity of hepatocellular carcinoma: the roles of sex hormones
2010
183
Metastatic colorectal cancer: from improved survival to potential cure
2010
183
Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer
2005
183
Cancer invasion and metastasis
2005
177
previous
2007
2008
2009
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.